Skip to content
Qi Group@NIBS

Qi Group@NIBS

  • Home
  • Publications
    • Medicinal chemistry
    • Methodology
    • Total Synthesis
  • Research
    • Medicinal Chemistry
  • Dr. Xiangbing Qi
  • Members
  • Resource
  • Group Activity
  • Contact

In Silico Identification of a Novel Hinge-Binding Scaffold for Kinase Inhibitor Discovery

2021-04-28 by admin

Yanli Wang, Yuze Sun, Ran Cao, Dan Liu, Yuting Xie, Li Li, Xiangbing Qi*, and Niu Huang*

          To explore novel kinase hinge-binding scaffolds, we carried out structure-based virtual screening against p38αMAPK as a model system. With the assistance of developed kinase-specific structural filters, we identify a novel lead compoundthat selectively inhibits a panel of kinases with threonine as the gatekeeper residue, including BTK and LCK. These kinases playimportant roles in lymphocyte activation, which encouraged us to design novel kinase inhibitors as drug candidates forameliorating inflammatory diseases and cancers. Therefore, we chemically modified our substituted triazole-class lead compoundto improve the binding affinity and selectivity via a “minimal decoration” strategy, which resulted in potent and selective kinaseinhibitors against LCK (18 nM) and BTK (8 nM). Subsequent crystallographic experiments validated our design. Theserationally designed compounds exhibit potent on-target inhibition against BTK in B cells or LCK in T cells, respectively. Ourwork demonstrates that structure-based virtual screening can be applied to facilitate the development of novel chemical entities incrowded chemical space in the field of kinase inhibitor discovery.

https://doi.org/10.1021/acs.jmedchem.7b01075

Post navigation

Previous Post:

Development of Dihydroxyphenyl Sulfonylisoindoline Derivatives as Liver-Targeting Pyruvate Dehydrogenase Kinase Inhibitors

Next Post:

a hybridiza-tionchain-reaction-based method for amplifying immunosignals

发表回复 取消回复

要发表评论,您必须先登录。

News

  • Radical Ring Expansion Catalyzed by an α-Ketoglutarate-Dependent Dioxygenase in the Biosynthesis of Tropolones
  • Cp*Ir(III)-Catalyzed Asymmetric Tandem Intramolecular Aziridination/Aza-Semipinacol Rearrangement of Alkenyl 1,4,2-Dioxazol-5-one
  • Structure-Based Optimization of TBK1 Inhibitors
  • Total synthesis of (±)-3-demethoxyerythratidinone via Tf2O-promoted cascade reaction of enaminone
  • Dissecting caspase-2-mediated cell death: from intrinsic PIDDosome activation to chemical modulation
© 2025 Qi Group@NIBS | National Institute of Biological Sciences, Beijing. Beijing ICP